J Korean Med Sci.  2011 Jul;26(7):886-892. 10.3346/jkms.2011.26.7.886.

Spectra of Chromosomal Aberrations in 325 Leukemia Patients and Implications for the Development of New Molecular Detection Systems

• Choi HJ
• Kim HR
• Shin MG
• Kook H
• Kim HJ
• Shin JH
• Suh SP
• Ryang DW

• KMID: 1094259
• DOI: http://doi.org/10.3346/jkms.2011.26.7.886

Abstract

This study investigated the spectrum of chromosomal abnormalities in 325 leukemia patients and developed optimal profiles of leukemic fusion genes for multiplex RT-PCR. We prospectively analyzed blood and bone marrow specimens of patients with acute leukemia. Twenty types of chromosomal abnormalities were detected in 42% from all patients by commercially available multiplex RT-PCR for detecting 28 fusion genes and in 35% by cytogenetic analysis including FISH analysis. The most common cytogenetic aberrations in acute myeloid leukemia patients was PML/PARA, followed by AML1/MGT8 and MLL1, and in acute lymphoid leukemia patients was BCR/ABL, followed by TEL/AML1 and MLL1 gene rearrangement. Among the negative results for multiplex RT-PCR, clinically significant t(3;3)(q21;q26.2), t(8;14)(q24;q32) and i(17)(q10) were detected by conventional cytogenetics. The spectrum and frequency of chromosomal abnormalities in our leukemia patients are differed from previous studies, and may offer optimal profiles of leukemic fusion genes for the development of new molecular detection systems.

Keyword

Leukemia; Chromosomal Abnormalities; Molecular Detection System

MeSH Terms

Adaptor Proteins, Signal Transducing/genetics
Adult
Aged
Aged, 80 and over
*Chromosome Aberrations
Chromosomes, Human, Pair 14
Chromosomes, Human, Pair 17
Chromosomes, Human, Pair 3
Chromosomes, Human, Pair 8
Core Binding Factor Alpha 2 Subunit/genetics
Female
Fusion Proteins, bcr-abl/genetics
Gene Rearrangement
Humans
In Situ Hybridization, Fluorescence
Karyotyping
Leukemia/diagnosis/*genetics
Leukemia, Myeloid, Acute/diagnosis/genetics
Male
Middle Aged
Myeloid-Lymphoid Leukemia Protein/genetics
Oncogene Proteins, Fusion/genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis/genetics
Reverse Transcriptase Polymerase Chain Reaction

Figure

• 

  Fig. 1 Representative chromosomal abnormalities. (A) Cryptic cytogenetic abnormalities were detected only in the multiplex RT-PCR system, which usually disclosed normal karyotype by conventional cytogenetic analysis. Positive band at 174base pair (arrow) in master PCR step turned out TEL/AML1 gene rearrangement by split out multiplex RT-PCR. (B) Some chromosomal abnormalities such as t(3;3) or t(8;14) should be included in multiplex RT-PCR system, which were not covered in the commercially available multiplex RT-PCR system. Arrows indicated t(3;3)(q21;q26.2). M, molecular weight marker.

Reference

1. Pallisgaard N, Hokland P, Riishøj DC, Pedersen B, Jørgensen P. Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood. 1998. 92:574–588.

2. Bacher U, Kern W, Schnittger S, Hiddemann W, Schoch C, Haferlach T. Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patients. Ann Hematol. 2005. 84:785–791.

3. Betts DR, Ammann RA, Hirt A, Hengartner H, Beck-Popovic M, Kuhne T, Nobile L, Caflisch U, Wacker P, Niggli FK. The prognostic significance of cytogenetic aberrations in childhood acute myeloid leukaemia. A study of the Swiss Paediatric Oncology Group (SPOG). Eur J Haematol. 2007. 78:468–476.

4. Klaus M, Haferlach T, Schnittger S, Kern W, Hiddemann W, Schoch C. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization. Cancer Genet Cytogenet. 2004. 155:47–56.

5. Look AT. Oncogenic transcription factors in the human acute leukemias. Science. 1997. 278:1059–1064.

6. Hutchings Hoffmann M, Wirenfeldt Klausen T, Hasle H, Schmiegelow K, Brondum-Nielsen K, Johnsen HE. Multiplex reverse transcription polymerase chain reaction screening in acute myeloid leukemia detects cytogenetically unrevealed abnormalities of prognostic significance. Haematologica. 2005. 90:984–986.

7. Strehl S, König M, Mann G, Haas OA. Multiplex reverse transcriptase-polymerase chain reaction screening in childhood acute myeloblastic leukemia. Blood. 2001. 97:805–808.

8. Elia L, Mancini M, Moleti L, Meloni G, Buffolino S, Krampera M, De Rossi G, Foà R, Cimino G. A multiplex reverse transcriptase-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia. Haematologica. 2003. 88:275–279.

9. Nakase K, Bradstock K, Sartor M, Gottlieb D, Byth K, Kita K, Shiku H, Kamada N. Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: a comparative study of Australian and Japanese adult cases. Leukemia. 2000. 14:163–168.

10. Cheng Y, Wang Y, Wang H, Chen Z, Lou J, Xu H, Qian W, Meng H, Lin M, Jin J. Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China. Leukemia. 2009. 23:1801–1806.

11. Pui CH. Acute lymphoblastic leukemia in children. Curr Opin Oncol. 2000. 12:3–12.

12. Pullarkat V, Slovak ML, Kopecky KJ, Forman SJ, Appelbaum FR. Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study. Blood. 2008. 111:2563–2572.

13. Amare P, Gladstone B, Varghese C, Pai S, Advani S. Clinical significance of cytogenetic findings at diagnosis and in remission in childhood and adult acute lymphoblastic leukemia: experience from India. Cancer Genet Cytogenet. 1999. 110:44–53.

14. Chang HH, Lu MY, Jou ST, Lin KH, Tien HF, Lin DT. Cytogenetics in childhood acute lymphoblastic leukemia in Taiwan: a single-institutional experience. Pediatr Hematol Oncol. 2006. 23:495–506.

15. Pinheiro RF, Chauffaille Mde L, Silva MR. Isochromosome 17q in MDS: a marker of a distinct entity. Cancer Genet Cytogenet. 2006. 166:189–190.

16. Kim MH, Hwang HY, Jeong SH, Kim YS, Eo WK, Park JS, Moon YH. Detection of p53 mutant and isochromosome 17q in myelodysplastic syndromes and leukemias. Korean J Clin Pathol. 2000. 20:349–353.